High Flow Nasal Therapy Use in Patients with Acute Exacerbation of COPD and Bronchiectasis: A Feasibility Study.
COPD
High flow nasal cannula
acute respiratory failure
bronchiectasis
humidification
mucus plug
sputum
Journal
COPD
ISSN: 1541-2563
Titre abrégé: COPD
Pays: England
ID NLM: 101211769
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
pubmed:
25
2
2020
medline:
29
6
2021
entrez:
25
2
2020
Statut:
ppublish
Résumé
The efficacy and feasibility of high flow nasal therapy (HFNT) use in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and bronchiectasis is unknown. We performed a single-center, single-arm prospective observational study in patients with AECOPD, documented bronchiectasis, pH ≥ 7.35, respiratory rate (RR) ≥ 26 breaths/minute despite receiving maximal medical treatment and oxygen
Identifiants
pubmed: 32088995
doi: 10.1080/15412555.2020.1728736
doi:
Substances chimiques
Carbon Dioxide
142M471B3J
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM